BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38309198)

  • 21. A comparative study of Candida species diversity among patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Sankari SL; Mahalakshmi K; Kumar VN
    BMC Res Notes; 2020 Oct; 13(1):488. PubMed ID: 33081839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Salivary Electrolytes Profile in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Saavedra JA; Novo DR; Mesko MF; Uchoa Vasconcellos AC; Duarte Da Silva K; Rojas Zuñiga G; Ramires RF; Tarquinio SBC
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):1031-1039. PubMed ID: 35345377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution tumour models paving the way for understanding oral carcinogenesis.
    Martins-Chaves RR; Silva RSO; Pereira TDSF; Fonseca FP; Gomez RS
    J Oral Pathol Med; 2023 Apr; 52(4):294-299. PubMed ID: 36622735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
    Errazquin R; Page A; Suñol A; Segrelles C; Carrasco E; Peral J; Garrido-Aranda A; Del Marro S; Ortiz J; Lorz C; Minguillon J; Surralles J; Belendez C; Alvarez M; Balmaña J; Bravo A; Ramirez A; Garcia-Escudero R
    Oral Oncol; 2022 Nov; 134():106184. PubMed ID: 36191479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive molecular screening for oral precancer in Fanconi anemia patients.
    Smetsers SE; Velleuer E; Dietrich R; Wu T; Brink A; Buijze M; Deeg DJ; Soulier J; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1102-11. PubMed ID: 26276748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma.
    Khan S; Alamgir MM
    J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Risk Human Papillomavirus in Patients with Oral Carcinoma and Oral Potentially Malignant Disorders in Serbia-A Pilot Study.
    Petrović A; Čanković M; Avramov M; Popović ŽD; Janković S; Mojsilović S
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893561
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral Premalignant and Malignant Lesions in Fanconi Anemia Patients.
    Archibald H; Kalland K; Kuehne A; Ondrey F; Roby B; Jakubowski L
    Laryngoscope; 2023 Jul; 133(7):1745-1748. PubMed ID: 36054728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review.
    Syrjänen S; Lodi G; von Bültzingslöwen I; Aliko A; Arduino P; Campisi G; Challacombe S; Ficarra G; Flaitz C; Zhou HM; Maeda H; Miller C; Jontell M
    Oral Dis; 2011 Apr; 17 Suppl 1():58-72. PubMed ID: 21382139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of autofluorescence in diagnosing oral squamous cell carcinoma and oral potentially malignant disorders: a comparative study with aero-digestive lesions.
    Luo X; Xu H; He M; Han Q; Wang H; Sun C; Li J; Jiang L; Zhou Y; Dan H; Feng X; Zeng X; Chen Q
    Sci Rep; 2016 Jul; 6():29943. PubMed ID: 27416981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of protein-based salivary markers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis.
    Arroyo E; Donís SP; Petronacci CMC; Alves MGO; Mendía XM; Fernandes D; Pouso AIL; Bufalino A; Bravo López S; Sayáns MP
    Cancer Biomark; 2021; 32(4):411-424. PubMed ID: 34334380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral cancer in Fanconi anemia: Review of 121 cases.
    Furquim CP; Pivovar A; Amenábar JM; Bonfim C; Torres-Pereira CC
    Crit Rev Oncol Hematol; 2018 May; 125():35-40. PubMed ID: 29650274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
    Amenábar JM; Torres-Pereira CC; Tang KD; Punyadeera C
    Cancer; 2019 Nov; 125(22):3936-3946. PubMed ID: 31390058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.
    Mazumder S; Basu B; Ray JG; Chatterjee R
    Arch Oral Biol; 2023 Mar; 147():105627. PubMed ID: 36657275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population.
    Hernández-Arenas YY; Támara-De Ávila JJ; Isaza-Guzmán DM; González-Pérez LV; Tobón-Arroyave SI
    J Oral Biosci; 2021 Jun; 63(2):217-223. PubMed ID: 33647453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of cytogenetic changes and chromosomal aneuploidy with fluorescent in situ hybridization in cytological specimens of oral cancers in Fanconi anemia-Proof of concept.
    Silva de Araujo BE; Velleuer E; Dietrich R; Pomjanski N; de Santana Almeida Araujo IK; Schlensog M; Wells SI; Dorsman JC; Schramm M
    Clin Exp Dent Res; 2022 Feb; 8(1):108-116. PubMed ID: 34854575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of CD44 and CD133 expression in oral potentially malignant disorder and oral squamous cell carcinoma].
    Jiajia Q; Yan S; Changqing Y; Wenjing J; Han Z; Yuanpan C; Qiuyan L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):311-316. PubMed ID: 28675018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the lesion surface suggesting transformation of oral potentially malignant disorders to malignancy - a report of eight cases.
    Kim MJ; Kho HS
    BMC Oral Health; 2023 May; 23(1):268. PubMed ID: 37161457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral squamous cell carcinomas and oral potentially malignant disorders: A Latin American study.
    Gilligan G; Panico R; Lazos J; Morelatto R; Belardinelli P; Criscuolo MI; Bolesina N; Molina Ávila I; Pimentel Solá JM; Rivarola E; Morgante MJ; Ingrassia Tonelli ME; Gimenez J; Doratti P; Werner LC; Prado-Ribeiro AC; Brandão TB; Vechiato-Filho AJ; Cuzzullin MC; Saldivia-Siracusa C; Lopes MA; Agostini M; Romañach MJ; Abrahão AC; Fonsêca TC; Kaminagakura E; Anbinder AL; Santos Alves K; de Almeida Lança ML; Sacsaquispe-Contreras S; Rodriguez Ibazetta K; Gerber-Mora R; Aranda Romo S; Tejeda Nava FJ; Cordero-Torres K; Moreno Silva R; Gonzalez-Arriagada W; Toro R; Silveira FM; Gonzalez N; Vargas PA; Santos-Silva AR; Bologna-Molina R; Villarroel-Dorrego M; Martinez B; Piemonte E
    Oral Dis; 2023 Oct; ():. PubMed ID: 37877476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.
    Li H; Liu Y; Zhou S; Zhou Q; Yang X
    BMC Oral Health; 2023 Sep; 23(1):659. PubMed ID: 37697274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.